Law Office of Brodsky & Smith, LLC Announces Investigation of Schiff
Nutrition International, Inc.
BALA CYNWYD, Pa. -- November 08, 2012
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Schiff Nutrition
International, Inc. (“Schiff” or the “Company”) (NYSE: SHF) relating to the
proposed acquisition by Bayer AG (“Bayer”).
Under the terms of the transaction, Schiff shareholders will receive only
$34.00 in cash for each share of Schiff common stock they own. The
investigation concerns possible breaches of fiduciary duty and other
violations of state law by the Board of Directors of Schiff for not acting in
the Company’s shareholders' best interests in connection with the sale process
to Bayer. The transaction may undervalue the Company as Schiff announced that
sales this fiscal year would increase by 40% to 43% after its acquisition of
the cold- prevention remedy Airborne. In addition, the investigation also
seeks to determine if conflicts of interests played a role in the transaction
as Schiff’s Board of Directors has agreed not to solicit any other competing
If you own shares of Schiff stock and wish to discuss the legal ramifications
of the proposed transaction, or have any questions, you may e-mail or call the
law office of Brodsky & Smith, LLC who will, without obligation or cost to
you, attempt to answer your questions. You may contact Jason L. Brodsky,
Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza,
Suite 602, Bala Cynwyd, PA 19004, by e-mail at
calling toll free 877-LEGAL-90.
Attorney Advertising. Past results do not guarantee a similar outcome.
Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J. Smith, Esquire
Press spacebar to pause and continue. Press esc to stop.